Fibromuscular Dysplasia Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting fibromuscular dysplasia clinical trials across 5 countries. Studies span Not Applicable. Top locations include Bristol, South West, United Kingdom, Brussels, Belgium, Cleveland, Ohio, United States. Updated daily from ClinicalTrials.gov.


Fibromuscular Dysplasia Trials at a Glance

8 actively recruiting trials for fibromuscular dysplasia are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Bristol, Brussels, and Cleveland. Lead sponsors running fibromuscular dysplasia studies include Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Icahn School of Medicine at Mount Sinai, and Cardiology Research UBC.

Browse fibromuscular dysplasia trials by phase

About Fibromuscular Dysplasia Clinical Trials

Looking for clinical trials for Fibromuscular Dysplasia? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fibromuscular Dysplasia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fibromuscular Dysplasia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia

Fibromuscular DysplasiaFibromuscular Dysplasia of ArteriesSpontaneous Coronary Artery Dissection
Vanderbilt University Medical Center2,000 enrolled1 locationNCT07529691
Recruiting
Not Applicable

A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia

Fibromuscular DysplasiaSpontaneous Coronary Artery Dissection
Mayo Clinic28 enrolled1 locationNCT07526766
Recruiting

Vascular Lab Resource (VLR) Biorepository

LymphedemaCardiovascular DiseasesMetabolic Disease+13 more
The Cleveland Clinic500 enrolled1 locationNCT05628948
Recruiting

Defining the Basis of Fibromuscular Dysplasia (FMD)

Fibromuscular DysplasiaCervical Artery DissectionSpontaneous Coronary Artery Dissection
Icahn School of Medicine at Mount Sinai600 enrolled1 locationNCT01967511
Recruiting

Renal Artery Fibromuscular Dysplasia Registry

Renal Artery Fibromuscular Dysplasia
Shanghai Jiao Tong University School of Medicine500 enrolled1 locationNCT05363748
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852
Recruiting
Not Applicable

European/International FMD Registry and Initiative

Fibromuscular Dysplasia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain5,000 enrolled1 locationNCT04804683
Recruiting

Canadian SCAD Study

Fibromuscular DysplasiaSCADSpontaneous Coronary Artery Dissection
Cardiology Research UBC3,000 enrolled1 locationNCT04906356